Pfizer Inc. said US regulators (FDA) have approved its cholesterol lowering drug Lipitor.辉瑞公司说，美国监管机构（ FDA ）的批准，其降胆固醇药物立普妥。 Lipitor is used to reduce the risk of stroke and heart attack in diabetic patients.立普妥是用来降低中风的风险和心脏病发作，在糖尿病患者。

The approval is for patients with type 2, or adult onset, diabetes (NIDDM) who have no signs of heart disease but have multiple risk factors (described below) for the condition.批准，是为病人与2型，或成人斯蒂尔，糖尿病（非胰岛素依赖型糖尿病）谁已没有任何迹象显示心脏疾病，但有多重危险因素（见下文）为条件。

Common risk factors include high cholesterol, high blood pressure, a family history of heart disease, smoking and obesity.常见的危险因素包括高胆固醇，血压高的压力，一个家庭心脏病史，吸烟和肥胖。